| Chibwesha, Carla J |
Univ Of North Carolina Chapel Hill
United States |
Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV |
5R01CA250850-05 |
|
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H. |
| Chirenje, Zvavahera Mike |
University Of California, San Francisco
United States |
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE) |
3UG1CA284918-03S1 |
|
Maria Silvina Frech, Ph.D., M.S. |
| Chong, Catherine Daniela |
Mayo Clinic Arizona
United States |
Biomarker Signature to Predict the Persistence of Post-Traumatic Headache |
5R33NS113315-03 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Chung, Raymond T |
Massachusetts General Hospital
United States |
Trial of Statins for Chemoprevention in Hepatocellular Carcinoma |
5R01CA255621-04 |
|
Asad Umar, D.V.M., Ph.D. |
| Chung, Michael Hoonbae |
Emory University
United States |
HIV/cervical cancer cOntrol and Prevention clinical sitE in Kenya (HOPE-Kenya) |
5UG1CA275400-03 |
|
Maria Silvina Frech, Ph.D., M.S. |
| Chung, Ki Young |
Prisma Health - Upstate
United States |
NCORP of the Carolinas (Greenville Health System NCORP) |
3UG1CA189972-11S1 |
|
Vanessa A. White, M.P.H. |
| Clapper, Margie L. |
Research Inst Of Fox Chase Can Ctr
United States |
Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis |
5R01CA262551-04 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Nancy J. Emenaker, Ph.D., RDN, LD, FAND |
| Clapper, Margie L. |
Research Inst Of Fox Chase Can Ctr
United States |
Novel small molecule agents to correct pathogenic VHL missense mutations |
3U54CA272686-03S1 |
RFA-CA-21-038 (U54 Clinical Trial Not Allowed) |
|
| Clare, Susan E. |
Northwestern University At Chicago
United States |
Lipid-initiated epigenetic reprogramming of the breast to a neural phenotype |
1R21CA288676-01A1 |
|
|
| Cocucci, Emanuele |
Ohio State University
United States |
A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL |
5R01CA270251-03 |
PAR-20-053 (R01 Clinical Trial Not Allowed) |
Matthew Young, Ph.D. |
